marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-22-2024
Medpace Holdings Balance Sheet 2011-2024 | MEDP
Annual Balance Sheet Medpace Holdings
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-81 M | 130 M | -314 M | - | -86.7 M | 56.4 M | 195 M | 127 M | 363 M | 437 M | - | - | - |
Long Term Debt |
142 M | 139 M | 131 M | - | - | 79.7 M | 205 M | 151 M | 378 M | 492 M | - | - | - |
Long Term Debt Current |
22.4 M | 19.3 M | 16.3 M | 15.9 M | 11 M | - | 16.5 M | 12.4 M | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 73.8 M | 121 M | 254 M | 200 M | 437 M | 561 M | - | - | - |
Total Current Liabilities |
925 M | 803 M | 557 M | 440 M | 343 M | 257 M | 193 M | 169 M | - | - | - | - | - |
Total Liabilities |
1.1 B | 966 M | 707 M | 585 M | 417 M | 378 M | 447 M | 368 M | 571 M | 695 M | - | - | - |
Deferred Revenue |
560 M | 463 M | 345 M | 256 M | 192 M | 148 M | 73.8 M | 65.7 M | 51.1 M | 58.1 M | - | - | - |
Retained Earnings |
-222 M | -360 M | 235 M | 115 M | 68.1 M | -41.5 M | -120 M | -9.58 M | -23 M | -14.3 M | - | - | - |
Total Assets |
1.66 B | 1.35 B | 1.66 B | 1.39 B | 1.14 B | 968 M | 951 M | 979 M | 984 M | 1.1 B | - | - | - |
Cash and Cash Equivalents |
245 M | 28.3 M | 461 M | 278 M | 132 M | 23.3 M | 26.5 M | 37.1 M | 17.7 M | - | - | - | - |
Book Value |
559 M | 386 M | 953 M | 806 M | 726 M | 590 M | 504 M | 611 M | 413 M | 402 M | - | - | - |
Total Shareholders Equity |
559 M | 386 M | 953 M | 806 M | 726 M | 599 M | 504 M | 611 M | 413 M | 402 M | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Medpace Holdings
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
128 M | 132 M | 136 M | 142 M | 143 M | 139 M | 143 M | 139 M | 139 M | - | 142 M | 131 M | 128 M | 113 M | 114 M | 115 M | 115 M | 115 M | 115 M | - | - | - | 55.8 M | 79.7 M | 79.7 M | 79.7 M | 79.7 M | 205 M | 205 M | 205 M | 205 M | 151 M | 151 M | 151 M | 151 M | 378 M | 378 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.2 B | 1.16 B | 1.12 B | 1.1 B | 1.02 B | 1.02 B | 1.05 B | 966 M | 979 M | - | 739 M | 707 M | 679 M | 618 M | 592 M | 585 M | 585 M | 585 M | 585 M | 417 M | 417 M | 417 M | 417 M | 378 M | 378 M | 378 M | 378 M | 447 M | 447 M | 447 M | 447 M | 368 M | 368 M | 368 M | 368 M | 571 M | 571 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
671 M | 638 M | 617 M | 560 M | 519 M | 491 M | 466 M | 463 M | 418 M | - | 367 M | 345 M | 304 M | 282 M | 278 M | 256 M | 256 M | 256 M | 256 M | 192 M | 192 M | 192 M | 192 M | 148 M | 148 M | 148 M | 126 M | 73.8 M | 68.3 M | 65.6 M | 60.5 M | 65.7 M | 65.7 M | 65.7 M | 65.7 M | 51.1 M | 51.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
65.6 M | -30.8 M | -119 M | -222 M | -300 M | -371 M | -408 M | -360 M | -380 M | - | -121 M | 235 M | 185 M | 142 M | 159 M | 115 M | 115 M | 115 M | 115 M | 68.1 M | 68.1 M | 68.1 M | 68.1 M | -41.5 M | -41.5 M | -41.5 M | -41.5 M | -120 M | -120 M | -120 M | -120 M | -9.58 M | -9.58 M | -9.58 M | -9.58 M | -23 M | -23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
2.08 B | 1.92 B | 1.8 B | 1.66 B | 1.49 B | 1.41 B | 1.4 B | 1.35 B | 1.33 B | - | 1.34 B | 1.66 B | 1.58 B | 1.47 B | 1.45 B | 1.39 B | 1.39 B | 1.39 B | 1.39 B | 1.14 B | 1.14 B | 1.14 B | 1.14 B | 968 M | 968 M | 968 M | 968 M | 951 M | 951 M | 951 M | 951 M | 979 M | 979 M | 979 M | 979 M | 984 M | 984 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
657 M | 511 M | 407 M | 245 M | 95.2 M | 39.1 M | 46.9 M | 28.3 M | 31 M | 42.6 M | 82.8 M | 461 M | 398 M | 339 M | 333 M | 278 M | 278 M | 278 M | 278 M | 132 M | 132 M | 132 M | 132 M | 23.3 M | 23.3 M | 23.3 M | 23.3 M | 26.5 M | 26.5 M | 26.5 M | 26.5 M | 37.1 M | 37.1 M | 37.1 M | 37.1 M | 14.9 M | 14.9 M | - | - | 54.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
881 M | 764 M | 672 M | 559 M | 471 M | 391 M | 347 M | 386 M | 350 M | - | 605 M | 953 M | 898 M | 852 M | 859 M | 806 M | 806 M | 806 M | 806 M | 726 M | 726 M | 726 M | 726 M | 590 M | 590 M | 590 M | 590 M | 504 M | 504 M | 504 M | 504 M | 611 M | 611 M | 611 M | 611 M | 413 M | 413 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
881 M | 764 M | 672 M | 559 M | 471 M | 391 M | 347 M | 386 M | 350 M | 283 M | 605 M | 953 M | 898 M | 852 M | 859 M | 806 M | 806 M | 806 M | 806 M | 726 M | 726 M | 726 M | 726 M | 599 M | 590 M | 590 M | 590 M | 509 M | 504 M | 504 M | 504 M | 611 M | 611 M | 611 M | 611 M | 413 M | 413 M | - | - | 402 M | - | - | 414 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency